EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Implementation of human milk antimicrobial peptides for immune protection in formula feeding

Alba Soledad Aquino-Domínguez, Nora Patricia Sánchez-Chávez, Sergio Roberto Aguilar-Ruiz, Abimael López-Hernández, Darío de Jesús Guillén-Morales, Karen Itaí Sanpedro-Montes, Areli Itzanami Martínez-Aquino, Guillermo Hernández-Jiménez

Exploration of Drug Science · 26.07.2026 · 4

DOI: 10.37349/eds.2026.1008173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Exploration of Drug Science, online erschienen am 26.07.2026. Verfasst von Alba Soledad Aquino-Domínguez und 7 weiteren Autor:innen. Die Arbeit nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human milk is widely recognized as the biological standard for early-life nutrition, providing both essential nutrients and bioactive components that support immune development. However, breastfeeding is not always feasible, and infant formula remains a necessary alternative in specific clinical and social contexts. Despite advances in formulation, significant immunological differences persist between breastfed and formula-fed infants, contributing to the so-called “immunological gap.” This review critically examines the potential of human milk-derived antimicrobial peptides (HM-AMPs) as functional ingredients to partially address this gap. Current evidence indicates that these peptides, derived from proteins such as lactoferrin, caseins, and α-lactalbumin, exhibit antimicrobial and immunomodulatory activities through mechanisms including membrane disruption and modulation of inflammatory pathways. However, most available data are derived from in vitro and preclinical models, limiting direct translation to clinical outcomes. In addition, significant challenges remain, including peptide instability during industrial processing, uncertain bioavailability in the gastrointestinal tract, and limited clinical validation. While emerging computational and bioengineering strategies offer opportunities to optimize peptide functionality, their large-scale implementation remains constrained by technological and regulatory factors. Overall, HM-AMPs represent a promising but still developing approach to improving infant formula functionality. Their contribution should be interpreted as partial and context-dependent, rather than as a complete replication of the immunological properties of human milk.

Zitieren

APA

Aquino-Domínguez, A. S., Sánchez-Chávez, N. P., Aguilar-Ruiz, S. R., López-Hernández, A., Guillén-Morales, D. D. J., Sanpedro-Montes, K. I., Martínez-Aquino, A. I., & Hernández-Jiménez, G. (2026). Implementation of human milk antimicrobial peptides for immune protection in formula feeding. Exploration of Drug Science, 4. https://doi.org/10.37349/eds.2026.1008173

Vancouver

Aquino-Domínguez AS, Sánchez-Chávez NP, Aguilar-Ruiz SR, López-Hernández A, Guillén-Morales DDJ, Sanpedro-Montes KI, et al. Implementation of human milk antimicrobial peptides for immune protection in formula feeding. Exploration of Drug Science. 2026;4. doi:10.37349/eds.2026.1008173

BibTeX
@article{AquinoDomnguez2026,
  author = {Aquino-Domínguez, Alba Soledad and Sánchez-Chávez, Nora Patricia and Aguilar-Ruiz, Sergio Roberto and López-Hernández, Abimael and Guillén-Morales, Darío de Jesús and Sanpedro-Montes, Karen Itaí and Martínez-Aquino, Areli Itzanami and Hernández-Jiménez, Guillermo},
  title = {Implementation of human milk antimicrobial peptides for immune protection in formula feeding},
  journal = {Exploration of Drug Science},
  year = {2026},
  volume = {4},
  doi = {10.37349/eds.2026.1008173}
}
Kostenlos starten →